Inside the South African lab that discovered Omicron
Access to the laboratory is strictly limited, for the risk of accidental infection is just too high.
Dec 9, 2021
0
4
Access to the laboratory is strictly limited, for the risk of accidental infection is just too high.
Dec 9, 2021
0
4
(HealthDay)—The Omicron variant appears to spread at twice the rate as the Delta variant does, due mostly to a combination of contagiousness and an ability to dodge the body's immune defenses, scientists report.
Dec 6, 2021
0
13
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.
Nov 26, 2021
0
2
Herpes type 1 is sealed with a kiss for a lifetime. More than half of U.S. adults are carriers of HSV1 (herpes simplex virus type 1) which hibernates in the peripheral nervous system and can never be eradicated.
Nov 17, 2021
0
193
The European Union's medicines agency on Monday began reviewing Merck's COVID-19 treatment pill so that it can swiftly advise national drug authorities in the 27-nation bloc that want to begin using it before it gets official ...
Nov 8, 2021
0
6
Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. It also is the first country to OK the treatment from drugmaker Merck, although it wasn't immediately clear ...
Nov 4, 2021
0
74
Does an infection also affect the immunization of subsequent generations? Researchers at Radboud University (Netherlands) have studied this together with the Universities of Bonn, Saarland (Germany), Lausanne (Switzerland) ...
Oct 18, 2021
0
319
For nearly a decade, scientists have known that HIV integrates itself into genes in cells that have the potential to cause cancer. And when this happens in animals with other retroviruses, those animals often develop cancer. ...
Oct 13, 2021
0
50
Genomic testing—the ability to read an individual's genetic code and identify their risk of conditions such as cancer—has opened up huge possibilities in personalized medicine.
Oct 5, 2021
0
7
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295